Ticker Details
Tango Therapeutics, Inc.
IPO Date:	September 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.03B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 4.19%
Avg Daily Range (30 D):	$0.95 | 3.42%
Avg Daily Range (90 D):	$1.09 | 4.29%

Institutional Daily Volume
Avg Daily Volume:	1.15M
Avg Daily Volume (30 D):	1.84M
Avg Daily Volume (90 D):	3.07M

Trade Size
Avg Trade Size (Sh.):	107
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	1,987
Avg Institutional Trade:	$2.26M
Avg Institutional Trade (30 D):	$3.07M
Avg Institutional Trade (90 D):	$2.91M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$3.54M
Avg Closing Trade (30 D):	$6.48M
Avg Closing Trade (90 D):	$10.54M
Avg Closing Volume:	261.42K

News

Aug 6, 2026 @ 10:24 PM Tango Therapeutics Announces Executive Chair Trans... Source: Na

Jun 10, 2026 @ 2:49 AM Tango Therapeutics Announces Pricing of $600 Milli... Source: Na

May 30, 2026 @ 12:27 AM Why This Fund Made a $189 Million Bet on Erasca as... Source: Jonathan Ponciano

May 30, 2026 @ 12:21 AM Tango Therapeutics Stock Is Up 840%, and This Fund... Source: Jonathan Ponciano

Mar 19, 2026 @ 3:00 PM The Patent Cliff is Coming, Driving Smart Money To... Source: Equity-Insider.Com

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.85	$-.37	$-.32
Diluted EPS	$-.86	$-.37	$-.32
Revenue	$53.81M	$M	$M
Gross Profit
Net Income / Loss	$-123.72M	$-55.34M	$-45.51M
Operating Income / Loss	$-136.35M	$-59.79M	$-48.77M
Cost of Revenue
Net Cash Flow	$305.86M	$187.73M	$45.12M
PE Ratio